Symbol="RPRX"
AssetType="Common Stock"
Name="Royalty PharmaÂ Plc"
Description="Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States. The company is headquartered in New York, New York."
CIK="1802768"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="110 EAST 59TH STREET, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="13692479000"
EBITDA="1183564000"
PERatio="41.28"
PEGRatio="-0.02"
BookValue="13.28"
DividendPerShare="0.77"
DividendYield="0.0261"
EPS="0.74"
RevenuePerShareTTM="5.35"
ProfitMargin="0.141"
OperatingMarginTTM="0.501"
ReturnOnAssetsTTM="0.0429"
ReturnOnEquityTTM="0.0612"
RevenueTTM="2359137000"
GrossProfitTTM="1332971000"
DilutedEPSTTM="0.74"
QuarterlyEarningsGrowthYOY="5.41"
QuarterlyRevenueGrowthYOY="0.217"
AnalystTargetPrice="48.54"
TrailingPE="41.28"
ForwardPE="10.85"
PriceToSalesRatioTTM="8.14"
PriceToBookRatio="2.994"
EVToRevenue="10.37"
EVToEBITDA="21.32"
Beta="0.387"
num_52WeekHigh="43.97"
num_52WeekLow="29.2"
num_50DayMovingAverage="31.37"
num_200DayMovingAverage="36.41"
SharesOutstanding="448199000"
DividendDate="2023-09-15"
ExDividendDate="2023-08-17"
symbol="RPRX"
open="30.51"
high="30.63"
low="30.14"
price="30.47"
volume="1848974.00"
latest_trading_day="2023-08-11"
previous_close="30.57"
change="-0.10"
change_percent="-0.3271%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="98"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="2"
Volume_recent_avg="2136487"
Change_recent_avg="-0.08"
Delta_recent_avg="0.63"
Variance_recent_avg="0.32"
Change_ratio_recent_avg="-0.25"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_60"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="2"
Aroon_momentum_negative="98"
image_negative_thumbnail_id_1="106"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0070.jpeg"
image_negative_thumbnail_id_2="119"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0057.jpeg"
image_neutral_thumbnail_id_1="522"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0077.jpeg"
image_neutral_thumbnail_id_2="572"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0027.jpeg"
image_positive_thumbnail_id_1="693"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0015.jpeg"
image_positive_thumbnail_id_2="607"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0101.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
